Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Firefly Neuroscience (AIFF) over the last 6 years, with Q3 2025 value amounting to $152000.0.

  • Firefly Neuroscience's Asset Writedowns and Impairment changed N/A to $152000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $874000.0 for FY2024, which is N/A changed from last year.
  • Firefly Neuroscience's Asset Writedowns and Impairment amounted to $152000.0 in Q3 2025.
  • Firefly Neuroscience's 5-year Asset Writedowns and Impairment high stood at $874000.0 for Q4 2024, and its period low was $152000.0 during Q3 2025.